Tyrogenex Secures $543,952 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    197 1st Avenue Needham Heights, MA 02494 USA
  • Company Description
    Founded in 2006, Tyrogenex is comprised of an experienced team that is dedicated to advancing next generation targeted therapeutics as promising new treatments to improve the lives of cancer patients.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 18 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy